Suppressive effects of furonaphthoquinone NFD-37 on the production of lipopolysaccharide-inducible inflammatory mediators in macrophages RAW 264.7

被引:0
作者
Kim Min-Hee
Shin Hyun-Mo
Lee Yong Rok
Chung Eun Yong
Chang Yoon Sook
Min Kyung Rak
Kim Youngsoo
机构
[1] Chungbuk National University,College of Pharmacy & Research Center for bioresource and Health
[2] Yeungnam University,School of Chemical Engineering and Technology
来源
Archives of Pharmacal Research | 2005年 / 28卷
关键词
Furonaphthoquinone; NO; PGE; Cytokine; Anti-inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
2-Methyl-2-(2-methylpropenyl)-2,3-dihydronaphthoquinone[2,3-b]furan-4,9-dione (NFD-37) is a synthetic furonaphthoquinone compound. In this study, we determined that NFD-37 could inhibit the lipopolysaccharide (LPS)-induced production of inflammatory mediators in macrophages RAW 264.7. This compound inhibited LPS-induced nitric oxide (NO) or prostaglandin (PG) E2 production in dose-dependent manners, with IC50 values of 7.2 μM and 5.3 μM, respectively. As the positive controls, pyrrolidine dithiocarbamate (30 μM) exhibited a 57% inhibition of NO production, and NS-398 (1 μM) manifested a 48% inhibition of PGE2 production. The inhibitory effects of NFD-37 on NO and PGE2 production were determined to occur in conjunction with the suppression of inducible NO synthase or cyclooxygenase-2 expression. NFD-37 also inhibited the production of LPS-inducible tumor necrosis factor-α, interleukin (IL)-1β and IL-6, at IC50 values of 4.8–8.9 μM. We also determined the anti-inflammatory efficacy of NFD-37 using carrageenin-induced paw edema in experimental mice.
引用
收藏
页码:1170 / 1176
页数:6
相关论文
共 86 条
[21]  
Hopkins S. J.(1999)TNFα and IL-1β are separate targets in chronic arthritis Clin. Exp. Rheumatol. 17 S105-S114
[22]  
Ignarro L. J.(1999)Dynamic regulation of pro-inflammatory cytokines Adv. Exp. Med. Biol. 461 153-178
[23]  
Inoue H.(2003)The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover Arthritis Rheum. 48 1177-1189
[24]  
Tanabe T.(undefined)undefined undefined undefined undefined-undefined
[25]  
Jones K. J.(undefined)undefined undefined undefined undefined-undefined
[26]  
Perris A. D.(undefined)undefined undefined undefined undefined-undefined
[27]  
Vernallis A. B.(undefined)undefined undefined undefined undefined-undefined
[28]  
Worthington T.(undefined)undefined undefined undefined undefined-undefined
[29]  
Lambert P. A.(undefined)undefined undefined undefined undefined-undefined
[30]  
Elliott T. S.(undefined)undefined undefined undefined undefined-undefined